Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2020, 29(2):73-77

Health-care workers and patient focused proposal for anti-epidemic management during the COVID-19 epidemics in Slovakia

Hatala R
Klinika kardiológie a angiológie Národný ústav srdcových a cievnych chorôb a. s. a Lekárská fakulta Slovenskej zdravotníckej univerzita v Bratislave, Slovenská republika

The aim of the presented proposal is to counteract the dramatic spread of the COVID-19 disease and to target reduction of its high case fatality rate by risk stratification during the early phases of the disease. Two key factors have contributed to the catastrophic extent of the disease in several countries: - Most of the known COVID-19 hotspots were locally preceded by massive gatherings of up to several hundred-thousand people (sporting events, religious pilgrimages etc.). - Widespread, mostly subclinical infection of health care workers (HCW) in the hospitals of the hotspot regions inabled a crucial dramatic virus transmission to elderly population. Replication of the former factor for virus spread is actually stoped by measures preventing people from assembling. However, HCW represent at least 11% of the total infected population and they still suffer from suboptimal availability of protective gear. The following targeted steps are proposed: 1. Continuous periodic PCR "pooled testing" of at least all frontline and hospital based HCW (optimally all HCW) at 7-day intervals and strict immediate quarantine of all SARS-CoV-2 positive persons. 2. Early targeted clinical examination of all symptomatic COVID-19 patients together with assessment of the several biomarkers (mainly parameters of inflammation, thrombophilia, and organ damage - heart and liver) aiming at early risk stratification. Thus, this proposal represents a complementary sustainable strategy to general anti-epidemic measures it could be of help to achieve 3 crucial goals: 1. To minimize virus spread in and from health-care facilities; 2. To protect HCW; 3. To identify COVID-19 patients at high risk for adverse, frequently lethal, outcome.

Keywords: COVID-19; testing; prognosis; biomarkers

Published: February 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hatala R. Health-care workers and patient focused proposal for anti-epidemic management during the COVID-19 epidemics in Slovakia. Cardiology Letters. 2020;29(2):73-77.
Download citation

References

  1. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020. doi: 10.1016/S0140-6736(20)30627-9 Go to original source...
  2. https://khn.org/news/true-toll-of-covid-19-on-u-s-health-careworkers-unknown/
  3. Lin L, Lu L, Cao W, et al. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia,Emerging Microbes & Infections 2020,9:1:727-732,DOI: 10.1080/22221751.2020.1746199 Go to original source...
  4. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. doi: 10.1001/jama.2020.1585 Go to original source...
  5. Fardet L, et al.Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66:2613-2620. doi: 10.1002/art.38690 Go to original source...
  6. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Go to original source...
  7. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628 Go to original source...
  8. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death inpatients with coronavirus disease 2019 pneumonia in Wuhan, China.JAMA Intern Med. 2020 Mar 13. doi: 10.1001/jamainternmed.2020.0994 Go to original source...
  9. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Mar 25. doi: 10.1001/jamacardio.2020.0950 Go to original source...
  10. Troponin and BNP Use in COVID-19 ACC Magazine.https://www.acc.org/latest-in-cardiology/articles/2020/03/18/15/25/ troponin-and-bnp-use-in-covid19
  11. Chapman, et al. High-sensitivity cardiac troponin can be an ally in the fight against COVID-19. Circulation 2020 pre-print 10.1161/CIRCULATIONAHA.120.047008 Go to original source...
  12. Han H, Xie L, Liu R, et al. Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China. J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25809. Go to original source...
  13. Kollias A, Kyriakoulis KG. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action- Br J Haematol. 2020 Apr 18. doi: 10.1111/bjh.16727. Go to original source...
  14. http://med.stanford.edu/news/all-news/2020/04/testing-pooledsamples-to-track-early-spread-of-virus.html
  15. https://aktuelles.uni-frankfurt.de/englisch/pool-testing-of-sars-cov02-samples-increases-worldwide-test-capacities-many-timesover/
  16. Yelin I, Aharony N, Tamar ES, et al. Evaluation of COVID-19 RT-qPCR test in multi-sample pools. MedRxiv preprint DOI https://doi.org/10.1101/2020.03.26.20039438
  17. Gattinoni L, et al. COVID-19 pneumonia: different respiratory treatment for different phenotypes? (2020) Intensive Care Medicine; DOI: 10.1007/s00134-020-06033-2.) Go to original source...